FLUOROQUINOLONE RESISTANCE AMONG METHICILLIN-RESISTANT STAPHYLOCOCCI AFTER USAGE OF FLUOROQUINOLONES OTHER THAN CIPROFLOXACIN IN TAIWAN

被引:8
作者
CHANG, SC [1 ]
HSIEH, WC [1 ]
LUH, KT [1 ]
机构
[1] NATL TAIWAN UNIV HOSP,DEPT CLIN PATHOL,TAIPEI 100,TAIWAN
关键词
D O I
10.1016/0732-8893(94)90056-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The antimicrobial susceptibility to norfloxacin, ofloxacin, and ciprofloxacin of methicillin-resistant staphylococci isolated before and after the use of fluoroquinolones other than ciprofloxacin in Taiwan was studied by the agar dilution method. Before the use of fluoroquinolones, 54 isolates of methicillin-resistant Staphylococcus aureus (MRSA) and 51 isolates of methicillin-resistant coagulase-negative staphylococci (MRCNS) isolated in 1983-1985 were all susceptible to the three fluoroquinolones tested. Following the use of norfloxacin, enoxacin, and ofloxacin, the MIC(90)s of norfloxacin, ofloxacin, and ciprofloxacin against 46 isolates of MRSA collected during 1989-1990 increased to 64, 16, and 32 mu g/ml, respectively, and the rates of resistant strains to these three agents were 37.0%, 30.4%, and 34.8%, respectively. The MIC(90)s against 42 isolates of MRCNS also increased to 64, 8, and 8 mu g/ml, respectively, with 35.7%, 23.8%, and 33.3% resistant strains.
引用
收藏
页码:143 / 147
页数:5
相关论文
共 18 条
[1]   COMPARISON OF THE ACTIVITIES OF COUMERMYCIN, CIPROFLOXACIN, TEICOPLANIN, AND OTHER NON-BETA-LACTAM ANTIBIOTICS AGAINST CLINICAL ISOLATES OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS FROM VARIOUS GEOGRAPHICAL LOCATIONS [J].
ALDRIDGE, KE ;
JANNEY, A ;
SANDERS, CV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) :634-638
[2]  
BLUM, 1992, ULO, V15
[3]   RAPID DEVELOPMENT OF CIPROFLOXACIN RESISTANCE IN METHICILLIN-SUSCEPTIBLE AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].
BLUMBERG, HM ;
RIMLAND, D ;
CARROLL, DJ ;
TERRY, P ;
WACHSMUTH, IK .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (06) :1279-1285
[4]  
Boyce J M, 1989, Infect Dis Clin North Am, V3, P901
[5]  
CHAMBERS H F, 1988, Clinical Microbiology Reviews, V1, P173
[6]  
CHANG SC, 1988, J FORMOS MED ASSOC, V87, P157
[7]   INCREASING RESISTANCE OF STAPHYLOCOCCUS-AUREUS TO CIPROFLOXACIN [J].
DAUM, TE ;
SCHABERG, DR ;
TERPENNING, MS ;
SOTTILE, WS ;
KAUFFMAN, CA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) :1862-1863
[8]   GYRA MUTATIONS IN CIPROFLOXACIN-RESISTANT, METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS FROM INDIANA, MINNESOTA, AND TENNESSEE [J].
FASCHING, CE ;
TENOVER, FC ;
SLAMA, TG ;
FISHER, LM ;
SREEDHARAN, S ;
ORAM, M ;
WILLARD, K ;
SINN, LM ;
GERDING, DN ;
PETERSON, LR .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (05) :976-979
[9]   INVITRO ACTIVITY OF CIPROFLOXACIN AGAINST METHICILLIN-SUSCEPTIBLE AND METHICILLIN-RESISTANT STAPHYLOCOCCI [J].
GAHRNHANSEN, B ;
SOGAARD, P ;
ARPI, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (05) :581-584
[10]  
MULLIGAN ME, 1987, AM J MED, V82, P215